Skip To Main Content
Kevin Cissy Nabukeera on Muck Rack

Kevin Cissy Nabukeera

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kevin Cissy

Contact Kevin Cissy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak

|
By Gradi Luakanda-Ndelemo, Alisen Ayitewala, Pascal Adroba-Tandele, Andrew Walakira, Adrienne Amuri-Aziza, Daan Jansen, Ronald Galiwango, Eddy Kinganda-Lusamaki, Andrew Tebba, Christian B. Ngandu, Aloysious Ssemaganda, Olivier Tshiani-Mbaya, Stephen Kanyerezi, Judith Kyokushaba, Hellen Rosette Oundo, Servet Kimbonza, Stephen Balinandi, Daniel Mukadi-Bamuleka, Valeria Nakintu, Justus Nsio, Ibrahimm Mugerwa, Daniel Kadobera, Sabue Mulangu, Ahidjo Ayouba, Henry Kyobe Bosa, Misaki Wayengera, Anne W. Rimoin, Benard Lubwama, Atek Kagirita, Steve Ahuka-Mundeke, Dieudonné K. Mwamba, Andrew Kambugu, Pontiano Kaleebu, Christian T. Happi, Laurens Liesenborghs, Miles W Carroll, Piet Maes, Jean B. Nachega, Martine Peeters, Pierre Akilimali, Allan N. Muruta, Jason Kindrachuk, Andrew Rambaut, Daniel J Kyabayinze, Charles Olaro, Koen Vercauteren, Susan Nabadda, Diana Atwine, Daudi Jjingo, Tony Wawina-Bokalanga, Placide Mbala-Kingebeni, Isaac Ssewanyana, Kevin Cissy Nabukeera, Syrus Semawule, Carol Makoha, Daniel Euriene, Micheal Eliu, Sam Gidudu, Ronnie Bahatungire
| Nature Verified
Abstract The 2026 Bundibugyo virus disease (BVD) outbreak in the DRC and Uganda raises urgent questions about the efficacy of existing Ebola virus (EBOV) monoclonal antibodies (mAbs) against Bundibugyo virus (BDBV). Here, we perform genomic and structural analyses of 44 BDBV sequences, including 12 from the 2026 outbreak, to assess mAb binding to the viral glycoprotein (GP).
Open in Who Shared Issue with article?
See all 1 articles